Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer

被引：0
|
作者：
Silvia Cantara
Eugenio Bertelli
Rossella Occhini
Marì Regoli
Lucia Brilli
Furio Pacini
Maria Grazia Castagna
Paolo Toti
机构：
[1] University of Siena,Department of Medical, Surgical and Neurological Sciences
[2] University of Siena,Department of Molecular and Developmental Medicine
[3] Arezzo Hospital,Unit of Pathology
[4] University of Siena,undefined
来源：
Endocrine | 2019年 / 64卷
关键词：
PD-L1; PD-1; Anaplastic thyroid cancer; Immunotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：122 / 129
页数：7
相关论文
共 50 条
  • [41] In Reply: Programmed Death-Ligand 1 (PD-L1) Immunohistochemistry Calibration
    Sompuram, Seshi R.
    Torlakovic, Emina E.
    t' Hart, Nils A.
    Vani, Kodela
    Bogen, Steven A.
    MODERN PATHOLOGY, 2023, 36 (02)
  • [42] Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma
    Vlahovic, Gordana
    Fecci, Peter E.
    Reardon, David
    Sampson, John H.
    NEURO-ONCOLOGY, 2015, 17 (08) : 1043 - 1045
  • [43] Programmed Death-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Expression in Aggressive Pediatric Lymphomas
    Coffey, Amy M.
    Curry, Jonathan L.
    Marcogliese, Andrea N.
    Tetzlaff, Michael T.
    Kamdar, Kala
    Elghetany, Mohamed T.
    Curry, Choladda V.
    LABORATORY INVESTIGATION, 2017, 97 : 344A - 344A
  • [44] Programmed Death-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Expression in Aggressive Pediatric Lymphomas
    Coffey, Amy M.
    Curry, Jonathan L.
    Marcogliese, Andrea N.
    Tetzlaff, Michael T.
    Kamdar, Kala
    Elghetany, Mohamed T.
    Curry, Choladda V.
    MODERN PATHOLOGY, 2017, 30 : 344A - 344A
  • [45] Inhibitory Effect of Hesperidin on the Expression of Programmed Death Ligand (PD-L1) in Breast Cancer
    Kongtawelert, Prachya
    Wudtiwai, Benjawan
    Shwe, Thuzar Hla
    Pothacharoen, Peraphan
    Phitak, Thanyaluck
    MOLECULES, 2020, 25 (02):
  • [46] Structure of the Complex of Human Programmed Death 1, PD-1, and Its Ligand PD-L1
    Zak, Krzysztof M.
    Kitel, Radoslaw
    Przetocka, Sara
    Golik, Przemyslaw
    Guzik, Katarzyna
    Musielak, Bogdan
    Domling, Alexander
    Dubin, Grzegorz
    Holak, Tad A.
    STRUCTURE, 2015, 23 (12) : 2341 - 2348
  • [47] Profile of programmed death ligand-1 (PD-L1) expression and PD-L1 gene amplification in Indonesian colorectal cancer patients.
    Budiyati, Akterono Dwi
    Putra, Teguh Pribadi
    Kusumo, Gita Dewi
    Rexana, Fritzie
    Kurniawan, Antonius
    Sudoyo, Aru Wisaksono
    Utomo, Ahmad Rusdan
    Utama, Andi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [48] PROGRAMMED CELL DEATH LIGAND 1 (PD-L1) PROTECTS AGAINST DEATH IN NEONATAL SEPSIS
    Wakeley, Michelle
    Chung, Chun-Shiang
    Ayala, Alfred
    SHOCK, 2020, 53 : 95 - 95
  • [49] Fusobacterium is enriched in oral cancer and promotes induction of programmed death-ligand 1 (PD-L1)
    Michikawa, Chieko
    Gopalakrishnan, Vancheswaran
    Harrandah, Amani M.
    Karpinets, Tatiana, V
    Garg, Rekha Rani
    Chu, Randy A.
    Park, Yuk Pheel
    Chukkapallia, Sasanka S.
    Yadlapalli, Nikhita
    Erikson-Carter, Kelly C.
    Gleber-Netto, Frederico Omar
    Sayour, Elias
    Progulske-Fox, Ann
    Chan, Edward K. L.
    Wu, Xiaogan
    Zhang, Jianhua
    Jobin, Christian
    Wargo, Jennifer A.
    Pickering, Curtis R.
    Myers, Jeffrey N.
    Silver, Natalie
    NEOPLASIA, 2022, 31
  • [50] Programmed death 1 (PD-1) and PD-1 ligand (PD-L1) distribution in triple negative breast cancer (TNBC)
    Baker, T. M.
    Gatalica, Z.
    Goldstein, L. J.
    Obeid, E.
    CANCER RESEARCH, 2017, 77
12345